In Brief: Cordis CrossFlex
This article was originally published in The Gray Sheet
Executive Summary
Cordis CrossFlex: Results of a 329 patient study of the tantalum coronary stent, presented at a Sept. 24 session of the Transcatheter Cardiovascular Therapeutics meeting in Washington, D.C., demonstrate a 41% restenosis rate for the 3.0 mm version, 11% for the 3.5 mm size and 5% for the 4.0 mm model, stated investigator Seung-Jung Park, MD, Asan Medical Center, Seoul, Korea. The device is currently available in international markets ("The Gray Sheet" July 21, I&W-8)...